Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications in Hematology
Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Immune Checkpoint Inhibitors in the Treatment of Virus-Associated Cancers
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Hypermethylation of the Alternative AWT1 Promoter in Hematological Malignancies Is a Highly Specific Marker for Acute Myeloid Leukemias Despite High Expression Levels
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Fact or Fiction - Identifying the Elusive Multiple Myeloma Stem Cell
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Monoacylglycerol Lipase Promotes Progression of Hepatocellular Carcinoma via NF-κB-mediated Epithelial-Mesenchymal Transition
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Association of Genetic and Immuno-Characteristics With Clinical Outcomes in Patients With RET-rearranged Non-Small Cell Lung Cancer: A Retrospective Multicenter Study
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Inosine Triphosphate Pyrophosphohydrolase (ITPA) Polymorphic Sequence Variants in Adult Hematological Malignancy Patients and Possible Association With Mitochondrial DNA Defects
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Targeting the Hsp90-Cdc37-Client Protein Interaction to Disrupt Hsp90 Chaperone Machinery
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Treatment of Localized Extranodal NK/T Cell Lymphoma, Nasal Type: A Systematic Review
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Superior Anti-Tumor Activity of the MDM2 Antagonist Idasanutlin and the BCL-2 Inhibitor Venetoclax in P53 Wild-Type Acute Myeloid Leukemia Models
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
‹
62
63
64
65
66
67
68
›